 |

In addition to the
Managers, RTV has assembled an exceptional Advisory Board to assist in
reviewing new investment opportunities and offering advice and counsel.
The General Partners
look to each individual Advisory Board Member to provide timely and accurate
recommendations and information. There are five primary functions targeted
for the Advisory Board Members:
- Identifying industry
segments to be investigated
- Reviewing selected
business plans or executive summaries for due diligence purposes
- Meeting with selected
entrepreneurs to review the markets and technology
- Providing other
sources of due diligence
- Assisting in deal
monitoring, on-going market relationships and exit strategies
The members of the
Advisory Board are as follows:
|
Bruce J. Boehm
Bruce is an
independent venture capitalist, an advisor to several specialty
venture capital funds, and an adjunct lecturer at the Kenan Flagler
School of Business at UNC, Chapel Hill. From 1992 to 1996 he created
and directed the Masters of Engineering Management Program at the
University of Canterbury in Christchurch, New Zealand. Prior to
1992 he was a General Partner of U. S. Venture Partners in Menlo
Park, California, with responsibility for a portfolio of approximately
20 health-care and technology investments. Prior to 1982 he was
employed by a number of Silicon Valley and Route 128 companies as
an engineer and project manager. Bruce received a BS from MIT, and
an MS and MBA from Stanford University. During his career he has
been a director of more than 25 publicly and privately held companies.
|
|
Kip Frey
Kip Frey is
currently the Technology Venture Partner at Intersouth Partners
and a Professor of the Practice in Entrepreneurial Management &
Law at Duke University with joint appointments from the Fuqua School
of Business and Duke Law School. Until June 2001, he was Vice President
and General Manager of Dynamic Commerce Applications for Siebel
Systems, Inc. (formerly OpenSite Technologies, Inc., an Intersouth
portfolio company). Prior to that he served as President and Chief
Executive Officer of OpenSite, which Siebel acquired in May of 2000.
Over the past
five years, Kip has been the architect of three of the Triangle's
most notable entrepreneurial deals, together generating more than
$1 billion of investor returns. In 1995, Kip negotiated and closed
the sale of Ventana Communications Group to the Thomson Corporation
for an undisclosed sum. He next became President of Accipiter, Inc.
and in 1998 sold the company to CMGI, Inc., structuring the transaction
so that the ultimate value of the deal approached $500 million.
Later in 1998, Kip moved to OpenSite, and in twenty months there
increased its value from $6 million to the acquisition price of
$550 million. In 1999, Digital South Magazine named him the Southeast's
top CEO. Kip is currently the Chairman of the Council for Entrepreneurial
Development (2001-2002).
Kip is an Adjunct
Professor at Duke's Sanford Institute for Public Policy Studies
and at Duke Law School, where he teaches courses in entrepreneurship
and intellectual property. He is a member of the Board of Directors
of the Raleigh Chamber of Commerce, the Council for Entrepreneurial
Development, Duke Law School's Board of Visitors, and several local
civic and charitable organizations. Kip is a Phi Beta Kappa graduate
of the University of Southern California Film School and of Duke
Law School.
|
|
John A. Irick
John has more
than 25 years of business experience in the bioscience industry.
He is currently Senior Vice President of Corporate and Business
Development for Biolex, Inc. Prior to that he was Executive Vice
President and Director of MERIX Bioscience, Inc., a venture-backed
immunotherapy company. As co-founder of MERIX, he served as Chief
Executive Officer during the organization and start-up of the company.
Previously, John was President, Chief Executive Officer and Director
of Apex Bioscience, Inc., a private, development-stage biotherapeutics
company. Prior to being recruited to Apex, he was Vice President
and Principal in The Shaw Group, a private life science incubator
holding company, and concurrently served as Vice President, Commercial
Development and Director of HemaGen/PFC, a private biopharmaceutical
company. John spent 14 years at Baxter Healthcare Corporation in
various management positions including Vice President in the Blood
Therapy Group, Managing Director of Baxter's Spanish subsidiary,
and Vice President of Business Operations at Baxter's Hyland Therapeutics
Division. He is Chairman and President of the North Carolina Biosciences
Organization (NCBIO) and a Director of the North Carolina Biotechnology
Center. He is a former member of the Emerging Companies Section
Governing Body and the Board of Directors of the Biotechnology Industry
Organization (BIO) and was appointed by Governor Hunt as the pharmaceutical/biotechnology
industry representative to the North Carolina Alliance for Competitive
Technologies board. John earned an A.B. in mathematical economics
from Brown University and an M.B.A. in marketing and finance from
the University of Chicago.
|
|
Brent Keating
Brent has been
involved in the knowledge based industries sector for over 17 years.
In his current role he is responsible for managing and developing
RBC Centura's Knowledge Based Industries (KBI) business throughout
the South Eastern United States. This includes managing and developing
relationships with public and private technology companies as well
as early stage venture backed technology companies.
Through his
work with technology companies, he has developed a good insight
into the needs and issues facing this sector. The experience gained
has enabled Brent to advise clients on matters of financial structuring,
acquisitions, and international trade. Over
the years Brent has been very involved with the industry, participating
in mentoring groups for early stage companies and serving as a board
member for several technology associations.
|
|
Dwight H. Sawin III
Dwight is presently
a private investor and consultant to various high technology companies.
He served as CEO of Millidyne, Inc. from 1988 to 1995 as the company
installed wireless communications systems worldwide. Prior to that
position Dwight served as Vice President for engineering and operations
for Millidyne, Millicom International Cellular, and at the Foxboro
Company. While at Millicom he was a member of the founding team
of Vodafone/Airtouch PLC. He serves, and has served, as a director
for several privately held companies in the technology and internet
arenas, including TaskPoint.com, Electrifier, LIPSinc and SciQuest.com.
Dwight earned his Ph.D., MSEE, and BSEE degrees from the University
of Idaho.
|
|
Daniel J. Shea
Dan is a retired
venture capitalist. He is a member of several organized groups of
investment angels including Charlotte Angel Partners, TriState Investment
Group in Chapel Hill, New Vantage Partners in Washington, DC and
Batterson Venture Partners in Chicago. Dan was formerly a partner
with Kitty Hawk Capital, a Charlotte, NC based venture capital firm.
Before that, Dan spent ten years with Scientific Advances, the venture
capital arm of Battelle Memorial Institute, a large independent
contract research organization. There, Dan both led and participated
in technology company investments in Silicon Valley, Boston's Route
128 and around the country. Prior to entering the venture capital
industry, Dan served as a consultant to venture capital firms and
technology-based companies in the San Francisco Bay area. Dan is
a member of the Entrepreneurial Development Board of the State of
North Carolina and a former director of the Council for Entrepreneurial
Development and the First Coast Venture Capital Group. He has been
a director of numerous venture capital-backed companies and is a
graduate of Brooklyn Polytechnic Institute, B.Chem.E. and Harvard
Business School, MBA.
|
|
Stephen Walsh Ph.D.
Steve co-founded
BOPS Inc. in 1997 and served as the first President of the company.
During the start-up phase, he was responsible for recruiting the
initial management and technical teams, managing start-up operations,
business planning, and initial fund raising activities. Steve worked
closely with the initial management team to further develop and
refine the BOPSŪ Business Plan and to assist in fund raising and
customer negotiations. Steve has over 17 years of industrial experience
in both technical and marketing positions. He holds a BSEE from
Rutgers College of Engineering, an MS and Ph.D. degrees in Electrical
Engineering from Duke University.
|
|
Catalysta Partners
Catalysta Partners
is a venture management firm focused on bringing technologies from
idea to market. Since 1998, the firm has been involved with over
20 clients and portfolio companies, providing key guidance regarding
the sales, marketing, and business development process, as well
as operating in strategic management roles inside companies. Through
Catalysta's venture arm, Catalysta Ventures, the firm plays a role
in co-founding companies by providing essential leadership, management
assistance, and financial investment early in a company's life.
As a team, Catalysta's partners bring over 100 years of entrepreneurial
and product commercialization experience in the Information Technology
and Life Sciences arenas. Key individuals within Catalysta Partners
working with RTV are as follows:
|
John Crumpler
John has over
20 years experience in birthing, building and managing top tier,
fast paced organizations and start-up ventures in a variety of
fields, including high tech, government, politics, and charitable
foundations. As the founder and top executive of E-Comm, Inc.,
a software integration firm in the Research Triangle, John's leadership
produced consistent annual triple digit revenue growth rates and
profits exceeding 35%. In 1996, E-Comm was acquired by XcelleNet,
Inc. to become XcelleNet Services, where John was President until
1998, when XcelleNet was acquired by Sterling Commerce for $240
million in cash and stock. John holds a BA from Harvard University.
|
Michael Jongkind
Michael has
been focused on technology business development throughout his
career. Recently, he was Vice President of Business Development
at SND, a software integration firm focused on the needs of the
pharmaceutical industry. At SND, he was responsible for business
partnerships and for the search process that led to SND's eventual
sale to E-Presence (formerly known as Banyan Systems) for $32
million in cash and stock. Prior to SND, Michael was a co-founder
and Vice President of E-Comm, where he focused on business development
and revenue generation from the company's inception in 1993 until
its acquisition by XcelleNet in 1997. Earlier, Michael was involved
in key sales, marketing, and business development roles with Bellsouth/RAM
Mobile Data and Nynex. Michael holds a BA in Telecommunications
from Indiana University.
|
Mark McCurry
Mark is an
experienced professional in sales and marketing of high technology
products. Mark was recently Senior Vice President of Worldwide
Sales for Per-Se Technologies, where he successfully rolled up
three separate software organizations acquired by Medaphis Corporation.
Total revenues for Per-Se Technologies were $300 million in 1998.
Mark also led U.S. sales operations for GEAC Smartstream, formerly
Dun & Bradstreet Software, where he was responsible for $110 million
in annual revenues and assisted in the successful sale of Dun
& Bradstreet Software to GEAC Smartstream. Pioneering early sales
in the emerging wireless mobile data market, Mark built a sales
organization for a $400 million joint venture between BellSouth
and Ram Broadcasting Corporation. Mark is a former member of the
Bellsouth Wireless Steering Committee. Mark holds a BA degree
in history from North Carolina A&T State University.
|
Clay Thorp
Prior to Catalysta,
Clay was the Director of Corporate Development at Novalon Pharmaceutical
Corporation, a biotechnology company in the Research Triangle.
Clay led business development, planning and capital development
efforts at the company from Novalon's inception in 1996 until
its sale to Karo Bio AB of Stockholm, Sweden in May 2000 in a
public stock transaction valued at $106.7 million. Prior to Novalon,
Clay was co-founder and President of Xanthon, Inc., a genomics
company focused on the analysis of gene expression using proprietary
electrochemistry, where he was responsible for developing the
company's business plan, securing the original venture investors,
and structuring the company's relationships with the University
of North Carolina at Chapel Hill and potential licensees of the
company's technologies. Clay holds a Master of Public Policy from
Harvard University and a BA from the University of North Carolina
at Chapel Hill in Mathematics and Art History.
|
|
|